Protein kinase C epsilon (PKCe), a novel PKC isoform, is overexpressed in prostate cancer (PCa) and correlates with disease aggressiveness. However, the functional contribution of PKCe to development or progression of PCa remained to be determined. Here we present the first in vivo genetic evidence that PKCe is essential for both the development and metastasis of PCa in the transgenic mouse model of prostate adenocarcinoma (TRAMP). Heterozygous or homozygous genetic deletions of PKCe in FVB/N TRAMP inhibited PCa development and metastasis as analyzed by positron emission tomography/computed tomography, tumor weight determinations, and histopathology. We also examined biomarkers associated with tumor progression in this model, including markers of survival, proliferation, angiogenesis, inflammation, and metastatic progression.
Introduction
Prostate cancer (PCa) is the most common type of cancer in American men and ranks second to lung cancer in cancerrelated deaths. The American Cancer Society has estimated that 217,730 new cases will be diagnosed and 32,050 deaths will occur in the United States alone in the year of 2010 (1) . The lack of effective therapies for advanced PCa is related to a large extent to the poor understanding for the molecular mechanisms underlying the progression of the disease toward invasion and metastasis (2) . Therefore, defining the novel molecular targets linked to PCa progression and metastasis will improve the planning strategies for the prevention and treatment of PCa.
PKC is a major intracellular receptor for the mouse skin tumor promoter 12-O-tetradecanoylphorbol-13-acetate. It represents a large family of phosphatidylserine (PS)-dependent serine/threonine kinases (3) (4) (5) (6) (7) . On the basis of structural similarities and cofactor dependence, 11 PKC isoforms have been classified into 3 subfamilies: the classic (cPKC), the novel (nPKC), and the atypical (aPKC). The cPKCs (a, bI, bII, g) are dependent on PS, diacylglycerol (DAG), and Ca 2þ . The nPKCs (d, e, h, and ) retain responsiveness to DAG and PS but do not require Ca 2þ for full activation. The aPKCs (l and z) require only PS for their activation (3) (4) (5) . PKC epsilon (PKCe) is involved in the regulation of diverse cellular functions including gene expression, neoplastic transformation, cell adhesion, mitogenicity, and cell invasion (8, 9) .
PKCe has been considered to be the hallmark of PCa development. Evidence suggests that overexpression of PKCe is sufficient to promote conversion of androgendependent LNCaP cells to androgen-independent (AI) variant, which rapidly initiates tumor growth in vivo in both intact and castrated athymic nude mice (10) . A recent study has shown that overexpression of PKCe protected LNCaP cells against apoptotic stimuli via inducing phosphorylation of Bad at Ser112 residue (11) . It has been shown that integrin signaling links PKCe to the PKB/AKT survival pathway in recurrent PCa cells (12) . Proteomic analysis of PCa CWR22 cells xenografts show that association of PKCe with Bax may neutralize apoptotic signals propagated through the mitochondrial death signaling pathway (13) . We and others have previously shown that PKCe level correlates with the aggressiveness of human PCa. Also, PKCe is overexpressed in PCa spontaneously developed in transgenic adenocarcinoma of the mouse prostate (TRAMP) mice, an autochthonous transgenic model that mimics to the human disease (14) . We have also shown that PKCe is a protein partner of transcription factor Stat3. PKCe associates with Stat3 and this association increases with the progression of the diseases in TRAMP mice and in human PCa. Taken together, all these findings suggest that PKCe is an oncogene and is involved in PCa development and aggressiveness and in the emergence of AI PCa (14) . However, the role of PKCe in PCa development and progression in intact mouse model remains elusive. We present here for the first time that genetic loss of PKCe in TRAMP mice prevents development and metastasis of PCa, possibly via downregulation of proliferative and metastatic genes.
Materials and Methods

Antibodies
Monoclonal or polyclonal antibodies specific for Bcl-xL, b-actin, COX-2, gp130, GAPDH (glyceraldehyde 3-phosphate dehydrogenase), PKCe, PKCa, PKCd, PKCbII, PKC, PKCg, PKCl, PKCz PKCe, PI3K85, PI3K110, PCNA (proliferating cell nuclear antigen), total Stat3, total Stat5, and VEGF were purchased from Santa Cruz Biotechnology. Blocking peptides for gp130 and Stat3 antibodies and mouse IgG were also procured from Santa Cruz Biotechnology. Monoclonal antibodies specific for pStat3Tyr705, and pStat3Ser727 were obtained from BD Biosciences. Antibodies specific to pAKTSer308, pAKTSer473, and total AKT were purchased from Cell Signaling Technology.
Experimental animals
FVB-TRAMP mice were provided by Dr. Barbara Foster, Roswell Park Cancer Institute, Buffalo, NY. PKCe KO mice were generated and provided by Dr. Michael Leitges, MaxPlank-Institut Fur Immunoliologie, and Freiburg, Germany. To create the bigenic mice, TRAMP mice (TG/WT//þ/þ) were crossbred with heterozygous (Het) null PKCe (WT/ WT//À/þ). TG/WT//À/þ and WT/WT//À/þ mice were obtained and crossbred to generate the TRAMP-PKCe WT (WT), TRAMP-PKCe Het (Het), and TG//PKCe KO (KO) mice. A total of 21 mice containing TG (n ¼ 7), Het (n ¼ 7), and KO (n ¼ 7) were used for the study. After 18 weeks, all the mice of TG, Het, and KO groups were euthanized and their blood was collected for serum preparation.
PET/CT scanning
Two animals from each group (TG, Het, and KO) were used for positron emission tomography (PET)/computed tomography (CT). We utilize a radioiodinated phospholipid ether analogue, 124 I-NM404. Following injection with 124 I-NM404, animals were anesthetized with isoflurane and scanned at desired time intervals by hybrid micro-CT/PET (100-mm spatial CT resolution, 40 million PET counts, filtered back projection image reconstruction).
Histopathologic examination
Prostate, lung, kidney, liver, and lymph nodes were excised and processed for histology as described previously (15) .
IL-6 ELISA assay
Interleukin 6 (IL-6) levels were determined from mouse serum by using specific ELISA kit for mouse IL-6 (eBioscience, Inc.). All of the procedures were followed by the manufacturer's protocol.
Immunoblot analysis
Tissues from PCa and brain were excised and whole tissue lysates were prepared. In brief, part of the PCa and brain tissues of TG, Het, and KO mice were homogenized in lysis buffer [50 mmol/L HEPES, 150 mmol/L NaCl, 10% glycerol, 1% Triton X-100, 1.5 mmol/L MgCl 2 , 10 mg/mL aprotinin, 10 mg/ mL leupeptin, 1 mmol/L phenylmethylsulfonyl fluoride (PMSF), 200 mmol/L Na 3 VO 4 , 200 mmol/L NaF, and 1 mmol/L EGTA (final pH 7.5)]. The homogenate was centrifuged at 14,000 Â g for 30 minutes at 4 C. Supernatants were collected and stored at À80 C until further use. Protein was estimated using Bio-Rad protein assay kit as per the manufacturer's protocol. Forty micrograms of tissue lysate were fractionated on 10% criterion precast SDS-polyacrylamide gel (Bio-Rad Laboratories). The protein was transferred to 0.45 mm Hybond-P polyvinylidene difluoride transfer membrane (Amersham Life Sciences). The membrane was then incubated with the indicated antibody followed by a horseradish peroxidase secondary antibody (Thermo Scientific), and the detection signal was developed with Amersham's enhanced chemiluminescence reagent using FOTO/Analyst Luminary Work Station (Fotodyne Inc.). The Western blots were quantitated by densitometric analysis by using Totallab Nonlinear Dynamic Image analysis software (Nonlinear USA, Inc.).
Electrophoretic mobility shift assay
Nuclear extracts were prepared from prostate tissues from TG, Het, and KO mice in a high-salt buffer [20 mmol/L HEPES (pH 7.9), 20 mmol/L NaF, 1 mmol/L Na 3 P 2 O 7 , 1 mmol/L Na 3 VO 4 , 1 mmol/L EDTA, 1 mmol/L EGTA, 1 mmol/L DTT, 0.5 mmol/L PMSF, 420 mmol/L NaCl, 20% glycerol, 1 mg/mL leupeptin, and 1 mg/mL aprotinin]. The samples were then centrifuged and harvested. Protein was estimated by using protein assay kit (Bio-Rad) as per the manufacturer's protocol. Stat3 DNA binding activity was determined in individual mouse nuclear lysates of each group. In brief, nuclear extracts (10 mg) were incubated in a final volume of 20 mL of 10 mmol/L HEPES (pH 7.9), 80 mmol/L NaCl, 10% glycerol, 1 mmol/L DTT, 1 mmol/L EDTA, and 100 mg/mL poly (deoxyinosinicdeoxycytidylic acid) for 15 minutes. A P 32 -radiolabeled doublestranded Stat3 consensus binding motif 5 0 -GATCCTTCTGG-GAATTCCTAGATC-3 0 (Santa Cruz Biotechnology) probe was then added and incubated for 20 minutes at room temperature. The protein-DNA complexes were resolved on a 4.5% nondenaturing polyacrylamide gel containing 2.5% glycerol in 0.25Â Tris-borate EDTA at room temperature, and gels were dried and autoradiographed. Stat3 DNA binding activities were determined.
Immunohistochemistry
To determine the expression of Stat3, IL-6 receptor (IL-6R), and PCNA proteins in prostatic intraepithelial neoplasia (PIN) and moderately and poorly differentiated (PD) adenocarcinoma of each mouse of TG and KO, we conducted immunohistochemistry in paraffin-embedded sections (4-mm thickness). In brief, sections were deparafffinized by placing the slides at 60 C for 2 hours followed by 3 changes of xylenes for 10 minutes each. Slides were placed in 0.3% methanol/ hydrogen peroxide for 20 minutes for quenching endogenous peroxidase. Slides were rehydrated in one change of absolute, 95%, 75%, and 50% ethanol and distilled water. Antigen retrieval was carried out by incubating samples at 116 C for 15 seconds in the declocking chamber by using a Trisurea solution (pH 9.5). After antigen retrieval, tissues slides were incubated with 2.5% normal horse serum (R.T.U. Vectastain Universal Elite ABC Kit; Vector Laboratories) for 20 minutes to block nonspecific binding of the antibodies. Subsequently, the slides were incubated over night with a mixture of Stat3 (1:50), IL-6R (1:50), and PCNA (1:50) dilution in normal antibody diluents (Scy Tek # ABB-125) in a humidified chamber. Blocking peptides of Stat3 and IL-6 antibodies were used to determine the specific immunoreactivity of these antibodies. We further confirmed the specificity of immunostaining of PCNA, IL-6, and Stat3 by using IgG antibody (served as a negative control). The mixture of antibodies was decanted, and the slides were washed thrice in TBS (pH 7.4). The slides were incubated with appropriate secondary antibodies for 30 minutes at room temperature. Slides were rinsed with TBS for 5 minutes and ABC reagent (Vector kit) was applied for 30 minutes. Immunoreactive complexes were detected using 3,3 0 -diaminobenzidine substrate (Thermo Scientific) and counter stained by using hematoxylin (Fischer Scientific) for nuclear staining. Finally, slides were mounted with cover slip by using mounting medium. All sections were visualized under a ZeissAxiophot DM HT microscope and images were captured with an attached camera. Dr. Weixiong Zhong, MD, a certified pathologist, examined all the slides. 
Quantitative real-time PCR array
Changes in expression of genes involved in the JAK/STAT signaling pathway was determined using real-time PCR (RT-PCR) arrays. In brief, excised PCa tissue from TG and KO mice were snap frozen and stored at À80 C. Total RNA was isolated using TRIzol reagent (Invitrogen) as per the manufacturer's instruction. RNA concentration and purity were checked by UV spectrophotometry, and RNA integrity was determined by electrophoresis. The first cDNA strand was synthesized using RT 2 First Strand Kit (SA Biosciences). The cDNA from either TG or KO PCa tissues was then applied to the RT 2 Profiler PCR Array for the JAK/STAT pathway (SA Biosciences) according to manufacturer's instructions. The RT-PCR reactions were run on the MyIQ (Bio-Rad) and the results (C t ), normalized to b-actin (DC t ), were determined using iQ5 software (Bio-Rad). Fold expression was determined as, where DDC t is DC t(KO) À DC t(TG) .
Statistical analysis
Student's t test was carried out to determine the significance. P < 0.05 was considered as significant.
Results
Generation and characterization of PKC«-deleted TRAMP mice
As shown in Figure 1A , TG, Het, and KO mice were generated by cross-breeding 6 to 7 weeks old homozygous TRAMP with PKCe Het mice ( 
Deletion of PKC« in TRAMP mice inhibits PCa development and metastasis
Accumulating evidence now indicates that PKCe is an oncogene which plays a vital role in the development of various types of human cancers including the prostate. Molecular genetic evidence of the role of PKCe in PCa development in an intact mouse model still remains obscure. In this study, we explored the possibility whether PKCe deletion in TRAMP mice inhibits the development and metastasis of PCa. A total of 21 mice (TG, n ¼ 7; Het, n ¼ 7; and KO, n ¼ 7) were used in this study. In our first experiment, we carried out micro-PET/ CT imaging, using a tumor selective radiopharmaceutical agent 124 I-NM404 (16) Fig. 2A (i and ii) ]. TG mice showed metastasis in proximal lymph node as evident by uptake of 124 I-NM404 [ Fig. 2A (i and ii) ]. However, no metastasis was observed in KO mice, suggesting the role of PKCe in the development and metastasis of PCa. All of the remaining mice from each group were sacrificed at the same age (18 weeks). Their bloods were collected from retro-orbital plexus for serum isolation. PCa tissues were excised and parts of the tissues were used in preparation of whole tissue lysates, nuclear lysates, RNA isolation, and histology sectioning as described in Material and Methods. Parts of the tissues excised from the kidneys, brains, livers, lungs, and lymph nodes were fixed in 10% buffered formalin and used for histopathology. Deletion of PKCe in TRAMP mice, or even one allele deletion, shows significant (P < 0.01) reduction in growth of PCa in all of the Het and KO mice ( Fig. 2C and D) . All TG mice developed 1 or 2 large-sized prostate tumors (Fig. 2C) , whereas Het and KO mice had only a single small-sized tumor (Fig. 2C) . One of the TG mice also showed grossly visible metastases in a local lymph node, both lungs, and the left kidney, which were confirmed by light microscopy ( Fig. 2E and F) . In addition, microscopic metastases were identified in another 3 TG mice. No metastasis was identified in any of the Het and KO mice ( Fig. 2G and H) . Hematoxylin and eosin (H&E)-stained tissue sections showed that all the grossly visible tumors were PD carcinomas characterized by solid sheets of large polymorphic cancer cells, with a high nucleus-to-cytoplasm ratio, frequent apoptosis, central necrosis, and neuroendocrine differentiation [ Fig. 3D (i) and E (i)]. Some of the Het and KO mice showed small foci of PD carcinoma at the microscopic level only. In addition, all the mice showed PIN characterized by epithelial cell proliferation with enlarged hyperchromatic nuclei and nuclear stratification in papillary and cribriform structures [ Fig. 3D (i) and E (i)].
Deletion of PKC« in TRAMP mice inhibits Stat3 activation
Aberrant activation of Stat3 has been linked to the progression of PCa metastasis (17) (18) (19) . A study suggests that overexpression of Stat3 in normal prostate epithelial cells leads to conversion of malignant phenotype (20) . To determine whether PKCe deletion in TRAMP mice inhibits Stat3 activation, we carried out immunoblot analysis in excised tissue PCa lysates of TG, Het, and KO mice. Results illustrated significant inhibition of both Ser727 and Tyr705 phosphorylation of Stat3 in both Het and KO mice (Fig. 3A) . A significant decrease in DNA binding activity of Stat3 was observed in Het and KO mice [ Fig. 3B (i and ii) ]. Immunohistochemistry results show a significant decrease in intensity of nuclear staining of Stat3 in PIN and PD PCa of KO mice [ Fig. 3C and E (ii)] compared with those in TG mice [ Fig. 3D (ii) ]. Specificity of Stat3 staining in TG PCa tumor tissue was confirmed using blocking peptide of Stat3 (Fig. 3F) .
Deletion of PKC« inhibits serum IL-6 and IL-6R gp130 expression
We have previously shown elevated levels of IL-6 in TRAMP mice compared with nontransgenic mice at the same age (14) . To determine whether deletion of PKCe in TRAMP mice decreases serum IL-6 levels, we carried out specific ELISA for mouse IL-6 and observed a significant (P < 0.05) decrease in serum IL-6 levels in Het and KO mice compared with TG mice (Fig. 4H) , suggesting that PKCe might be initiator of the IL-6/ Stat3 signaling pathway. IL-6R (gp130) is one of the downstream target genes of Stat3. Immunohistochemistry results showed a significant decrease in the protein levels of IL-6R in KO mice compared with TG mice (Fig. 4A) . Weak immunostaining of IL-6R was observed in benign epithelial cells and moderate staining in PD carcinoma cells of both TG and KO mice [ Fig. 4E (i) ], although there is strong immunostaining of IL-6R in PIN of TG mice and only moderate staining in PIN of KO mice [ Fig. 4D (i) ]. Specific immunoreactivity of IL-6R was confirmed by using blocking peptide of IL-6R antibody [ Fig. 4F (i) ].
Deletion of PKC« inhibits markers of proliferation, antiapoptosis, and metastasis
Evidence from published studies, including our laboratory, suggests modulation of various apoptotic and proliferative biomarkers in PCa in both humans and TRAMP mice during the progression and metastasis (14, 21) . To determine possible changes in biomarkers involved in apoptosis, proliferation, and metastasis of PCa in PKCe-deleted TRAMP mice, we conducted immunoblot analysis of selected biomarkers in PCa tissue lysates of TG, Het, and KO mice. We observed a decrease in the protein levels of Bcl-xL, COX-2, cyclin D1, and VEGF in Het and KO mice ( Fig. 4A and B) . We have previously shown overexpression of PI3K/AKT in PCa tissues of TRAMP mice compared with nontransgenic prostate tissues at the same age (14) . We observed a decrease in the protein levels of regulatory subunit (p85b) of PI3K in Het and KO mice but no change was observed in the protein levels of catalytic isoform (p110b) of PI3K (Fig. 4B) , pAKTSer473, or pAKTSer308 (Fig. 4C) . We also carried out immunohistochemistry of PCNA in PCa tissues of TG and KO mice and observed a significant decrease in the nuclear levels of PCNA in PIN and PD PCa of KO mice [ Fig. 4E (ii)-G].
Quantitative PCR array identifies decreased transcripts of genes implicated in PCa development and metastasis
To further define the role of PKCe in modulating the other genes associated with JAK/STAT3 signaling and involved in PCa development and metastasis, we carried out quantitative RT-PCR (qRT-PCR) array of genes associated with JAK/STAT signaling pathway on total RNA isolated from PCa tissues of TG and KO mice. This array contained 84 genes related to JAK/ STAT family members, the receptors that activate them, nuclear cofactor and coactivators associated with the Stat proteins, Stat-inducible genes, and negative regulators. A significant decrease in the mRNA expression of CCAAT/enhancer binding protein b (C/EBPb; 2.5-fold), C-reactive protein (CRP; 4.34-fold), epidermal growth factor receptor (EGFR; 4.54-fold), gp130 (2.5-fold), Jun B (2.5-fold), and Stat3 (2.85-fold) was observed in KO mice compared with TG mice (Table 1) . These results indicate that PKCe directly and/or indirectly regulates the expression of Stat3 and Stat3 downstream target genes involved in PCa development and metastasis.
Discussion
In this study, we for the first time investigated PKCe link between the development and metastasis of PCa in transgenic Cancer Researchmouse model (TRAMP). We used a molecular genetic approach to generate bigenic TRAMP mice, which were also either wild-type, heterozygous null, or homozygous null for PKCe. Deletion of PKCe did not affect other isoforms of PKC in Het or KO mice, suggesting no compensatory effect of PKCe deletion in TRAMP mice. All of the PKCe-deleted TRAMP mice were healthy and we did not observe any gross pathologic changes in any organs of these animals. TRAMP PCa closely mimics human PCa, as they both spontaneously develop progressive PCa. TRAMP PCa is invasive and capable of metastasis to distant sites, primarily to pelvic lymph nodes and to the lungs (22) . Mouse genetic background affects the development of TRAMP PCa. TRAMP mice on FVB/N background more readily develop PIN compared with TRAMP mice on C57Black/B16 background (22) . In our study, we observed that deletion of PKCe in TRAMP mice prevents tumor development, which was evident by a lack of focal uptake of 124 I-NM404, a selective tumor agent [ Fig. 2B  (ii) ]. This was followed by a significant (P < 0.01) decrease in prostate tumor weight in Het and KO animals ( Fig. 2C and D) . Metastasis of PCa to distant organs is the main cause of morbidity and mortality in PCa patients. Importantly, we observed the metastasis of PCa to lungs, lymph nodes, and kidneys of the 70% TG animals, which was evident by the uptake of 124 I-NM404 into the lymph nodes. Histopathologic examinations of lungs, lymph nodes, and kidneys of TG mice further confirm the metastasis of PCa. However, no metastasis was detected in any of the animals, even in the 2 mice from each Het and KO groups that had PCa. Taken together, these results strongly support that loss of PKCe inhibits both primary PCa and metastasis.
PCa is heterogeneous in nature, which involves activation of multiple signaling pathways. Constitutive activation of the transcription factor Stat3 has been shown to be a marker of poor prognosis in human PCa. Activation of Stat3 has been linked to the PCa development and metastasis through the induction of various genes responsible for tumor cell proliferation, cell survival, and carcinogenesis (17) (18) (19) . In our previous studies, we have shown that PKCe activates and physically interacts with Stat3 in various types of human cancer cells including the prostate (23) . In this study, loss of PKCe in TRAMP mice inhibited activation of Stat3, which was manifested by significant inhibition of both pStat3Ser727 and pStat3Tyr705 protein levels and decreased Stat3-DNA binding activity. Decrease in Stat3 nuclear staining was observed in PIN and PD adenocarcinoma of KO mice. These results are in accordance with our previously published reports, in which we have shown the interaction of PKCe with Stat3 during development of skin carcinoma in PKCe transgenic mice (24) . These data further proves that PKCe may be an initiator for activation of Stat3 during PCa development. IL-6 is involved in activation of Stat3, which phosphorylates tyrosine residue of Stat3. Higher level of serum IL-6 has been associated with larger PCa burden, especially bone metastases (25, 26) . In our study, KO mice showed a significant (P < 0.05) decrease in serum IL-6 and its receptor gp130, which indicates that PKCe may have a direct or indirect role in potentiating the autocrine loop of IL-6 signaling in PCa. However, further detail investigation is warranted to understand the molecular mechanism of PKCe-mediated IL-6 signaling during the PCa development and metastasis. We further investigated various downstream target genes of Stat3 which have a role in the PCa inflammation, proliferation, angiogenesis, and metastasis (COX-2, cyclin D1, VEGF, Bcl-xL, IL-6R) which were significantly inhibited in KO mice. These data further provide evidence that PKCe is linked to activation of Stat3. PCNA is a nuclear protein, which has been known as a cell proliferative marker, and a decrease in the expression of PCNA reflects cell-cycle arrest in G 1 /S phase (27) . We observed a significant decrease in the expression of PCNA in KO mice. These data correspond to the previous study, which has shown that knockdown of PKCe in PCa LNCaP cells arrested the cell cycle in G 1 /S phase (10) . We also conducted focused qRT-PCR arrays of genes involved in the JAK/STAT signaling pathway in TG and KO PCa tissues to determine the role of PKCe in JAK/STAT signaling. A significant decrease in mRNA expression of CEBPb, CRP, EGFR, gp130, Jun B, and Stat3 was observed in KO mice compared with TG mice (Table 1) . These results further provide clues about the role of PKCe in activation of Stat3 and other signaling molecules linked to the PCa development and metastasis. However, a detailed investigation is warranted to find out the cross-talk of PKCe with JAK/STAT signaling pathway-associated molecules. In summary, deletion of PKCe in FVB/N TRAMP mice inhibits PCa development and metastasis. We have previously reported that Stat3 is a protein partner of PKCe (14, 23) . PKCe interacts with Stat3 and phosphorylates Stat3Ser727, essential for Stat3 activation and nuclear localization (14) . In consistent with previous findings, deletion of PKCe in FVB/N TRAMP mice downregulated prostatic Stat3 activation and Stat3-regulated gene expressions. We conclude that PKCe and its downstream protein partner Stat3 constitute essential components of the signal transduction pathways involved in PCa development and metastasis. Therefore, we suggest that targeting PKCe is a novel approach for prevention or treatment of PCa.
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